Atefeh Arab

765 total citations
23 papers, 623 citations indexed

About

Atefeh Arab is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Atefeh Arab has authored 23 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Atefeh Arab's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and RNA Interference and Gene Delivery (8 papers). Atefeh Arab is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and RNA Interference and Gene Delivery (8 papers). Atefeh Arab collaborates with scholars based in Iran, Canada and Netherlands. Atefeh Arab's co-authors include Rezvan Yazdian‐Robati, Javad Behravan, Khalil Abnous, Mohammad Ramezani, Seyed Mohammad Taghdisi, Nastaran Barati, Mahmoud Reza Jaafari, Atefeh Razazan, Fatemeh Mosaffa and Amin Reza Nikpoor and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Atefeh Arab

21 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atefeh Arab Iran 15 381 244 200 156 102 23 623
Wenhao Li China 14 420 1.1× 333 1.4× 143 0.7× 82 0.5× 62 0.6× 32 710
Xun Zhu China 11 490 1.3× 143 0.6× 146 0.7× 57 0.4× 63 0.6× 28 724
Luke J. Kubiatowicz United States 11 370 1.0× 141 0.6× 196 1.0× 104 0.7× 32 0.3× 17 623
Wenyun Zheng China 13 289 0.8× 75 0.3× 94 0.5× 49 0.3× 48 0.5× 52 471
Estelle J. A. Suys Australia 10 472 1.2× 142 0.6× 133 0.7× 62 0.4× 22 0.2× 10 811
Huihui Zhu China 15 355 0.9× 146 0.6× 123 0.6× 60 0.4× 12 0.1× 40 648
Julieta M. Sánchez Argentina 16 472 1.2× 69 0.3× 60 0.3× 44 0.3× 90 0.9× 55 711
Michelle K. Greene United Kingdom 14 210 0.6× 56 0.2× 149 0.7× 124 0.8× 98 1.0× 24 464
Kohta Mohri Japan 15 709 1.9× 260 1.1× 179 0.9× 30 0.2× 24 0.2× 29 948
Arnab Rudra United States 10 953 2.5× 207 0.8× 82 0.4× 114 0.7× 27 0.3× 15 1.2k

Countries citing papers authored by Atefeh Arab

Since Specialization
Citations

This map shows the geographic impact of Atefeh Arab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atefeh Arab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atefeh Arab more than expected).

Fields of papers citing papers by Atefeh Arab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atefeh Arab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atefeh Arab. The network helps show where Atefeh Arab may publish in the future.

Co-authorship network of co-authors of Atefeh Arab

This figure shows the co-authorship network connecting the top 25 collaborators of Atefeh Arab. A scholar is included among the top collaborators of Atefeh Arab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atefeh Arab. Atefeh Arab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arab, Atefeh, et al.. (2025). The potential of polyphenols and polyphenol-rich extracts against human papillomavirus infections and associated cancers. Journal of Functional Foods. 129. 106873–106873.
3.
Arab, Atefeh, Amin Reza Nikpoor, Peyman Asadi, et al.. (2022). Virus-like nanoparticles (VLPs) based technology in the development of breast cancer vaccines. Process Biochemistry. 123. 44–51. 7 indexed citations
4.
Momtazi‐Borojeni, Amir Abbas, Atefeh Razazan, Mercedeh Mansourian, et al.. (2020). Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer. PLoS ONE. 15(12). e0243550–e0243550. 15 indexed citations
5.
Arab, Atefeh, Rezvan Yazdian‐Robati, & Javad Behravan. (2020). HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development. Archivum Immunologiae et Therapiae Experimentalis. 68(1). 2–2. 67 indexed citations
6.
Barati, Nastaran, Amir Abbas Momtazi‐Borojeni, Atefeh Arab, et al.. (2019). P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer. Artificial Cells Nanomedicine and Biotechnology. 47(1). 664–672. 29 indexed citations
7.
Razazan, Atefeh, Roderick Slavcev, Nastaran Barati, et al.. (2019). Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice. Scientific Reports. 9(1). 2221–2221. 31 indexed citations
8.
Yazdian‐Robati, Rezvan, Atefeh Arab, Mohammad Ramezani, et al.. (2019). Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo. Drug Development and Industrial Pharmacy. 45(4). 603–610. 34 indexed citations
9.
Barati, Nastaran, Atefeh Razazan, Roderick Slavcev, et al.. (2018). Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice. Cancer Letters. 424. 109–116. 26 indexed citations
10.
Arab, Atefeh, Amir Abbas Momtazi‐Borojeni, Nastaran Barati, et al.. (2018). Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer. Journal of Cellular Biochemistry. 120(2). 1294–1303. 17 indexed citations
11.
Arab, Atefeh, et al.. (2018). Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer. Current Pharmaceutical Design. 24(11). 1195–1203. 6 indexed citations
12.
Arab, Atefeh, et al.. (2018). The viral approach to breast cancer immunotherapy. Journal of Cellular Physiology. 234(2). 1257–1267. 27 indexed citations
13.
Arab, Atefeh, Javad Behravan, Atefeh Razazan, et al.. (2017). A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. Journal of drug targeting. 26(4). 365–372. 38 indexed citations
14.
Emami, Seyed Ahmad, et al.. (2017). Anti-melanogenic activity of different extracts from aerial parts of Nepeta glomeruloasin on murine melanoma B16F10 cells. Iranian journal of pharmaceutical sciences. 13(2). 61–74. 2 indexed citations
15.
Razazan, Atefeh, Javad Behravan, Atefeh Arab, et al.. (2017). Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS ONE. 12(10). e0185099–e0185099. 46 indexed citations
16.
Yazdian‐Robati, Rezvan, Atefeh Arab, Mohammad Ramezani, Khalil Abnous, & Seyed Mohammad Taghdisi. (2017). Application of aptamers in treatment and diagnosis of leukemia. International Journal of Pharmaceutics. 529(1-2). 44–54. 38 indexed citations
17.
Abnous, Khalil, Atefeh Arab, Maryam Akaberi, et al.. (2017). Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Bioorganic & Medicinal Chemistry. 25(3). 1294–1302. 31 indexed citations
18.
Arab, Atefeh, Roderick Slavcev, Atefeh Razazan, et al.. (2017). Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response. Immunologic Research. 66(1). 200–206. 28 indexed citations
19.
Barati, Nastaran, Amin Reza Nikpoor, Atefeh Razazan, et al.. (2017). Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer. Immunology Letters. 190. 108–117. 24 indexed citations
20.
Yazdian‐Robati, Rezvan, et al.. (2016). Aptasensors for quantitative detection of kanamycin. Biosensors and Bioelectronics. 82. 162–172. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026